Trademark Overview
On Friday, January 17, 2025, a trademark application was filed for PREDIDIAB PRÉDIRE POUR PRÉVENIR with the United States Patent and Trademark Office. The USPTO has given the PREDIDIAB PRÉDIRE POUR PRÉVENIR trademark a serial number of 79419015. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, August 12, 2025. This trademark is owned by PrédiDiab. The PREDIDIAB PRÉDIRE POUR PRÉVENIR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and veterinary products sold on prescription or over the counter; sanitary products for medicine; dietetic substances for medical use; chemical preparations for medical or pharmaceutical use; vaccines; food for babies; plasters, material for dressings; disinfectants; vitamins, vitamin-based preparations, dietetic substances for medical use; natural dietetic foods and remedies based on medicinal plants for medical or veterinary use; beverages and foodstuffs for medicinal use; food supplements and additives for medicinal use; mineral food supplements for medicinal use; nutritional supplements, plant-based preparations for medicinal use; food supplements containing proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, for medical use; plant-based products and plant extracts for medicinal use; preparations for making dietetic or medicated beverages; medicinal preparations; chemical preparations for ...
Scientific and technological services, and also assorted development and design; medical and pharmacological research services; development of pharmaceutical products, carrying out evaluations of pharmaceutical products, carrying out testing on pharmaceutical products, laboratory research services concerning pharmaceutical products; computer programming in the medical field; advisory services for professionals and patients in the field of diabetes; management of data for medical use; information and advisory services; providing scientific and pharmaceutical expertise.
